| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 14, 2026 | Option exercise(M) | 10K | $7.80 | $78K | 41K |
| Aug 14, 2026 | Option exercise(M) | 42K | $12.50 | $525K | 83K |
| Aug 14, 2026 | Sell(S) | 4K | $106.05 | $385K | 79K |
| Aug 14, 2026 | Sell(S) | 10K | $107.14 | $1.1M | 69K |
| Aug 14, 2026 | Sell(S) | 15K | $107.97 | $1.6M | 54K |
| Aug 14, 2026 | Sell(S) | 10K | $109.11 | $1.1M | 44K |
| Aug 14, 2026 | Sell(S) | 9K | $110.00 | $1.0M | 35K |
| Aug 14, 2026 | Sell(S) | 4K | $111.14 | $428K | 31K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 14, 2026 | Option exercise(M) | 10K | — | $0 | 90K |
| Aug 14, 2026 | Option exercise(M) | 42K | — | $0 | 121K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0000907654-26-000077) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Oruka Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.